CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

Item
http://www.wikidata.org/entity/Q34134934
Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signalingThe aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancersRole of DUSP1/MKP1 in tumorigenesis, tumor progression and therapyThe investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imagingAsparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancersTargeting the mitogen-activated protein kinase cascade to treat cancer.Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.Targeting the ERK signaling pathway in cancer therapy.Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions.Ovarian cancer molecular pathology.The regulatory roles of phosphatases in cancer.Anti-TNF effects on destructive fibroblasts depend on mechanical stress.Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy.Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response.The impact of phosphatases on proliferative and survival signaling in cancer.
P2860

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

Item
http://www.wikidata.org/entity/Q34134934
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CL100 expression is down-regul ...... eases its malignant potential.
@ast
CL100 expression is down-regul ...... eases its malignant potential.
@en
CL100 expression is down-regul ...... eases its malignant potential.
@nl
type
label
CL100 expression is down-regul ...... eases its malignant potential.
@ast
CL100 expression is down-regul ...... eases its malignant potential.
@en
CL100 expression is down-regul ...... eases its malignant potential.
@nl
prefLabel
CL100 expression is down-regul ...... eases its malignant potential.
@ast
CL100 expression is down-regul ...... eases its malignant potential.
@en
CL100 expression is down-regul ...... eases its malignant potential.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P4510
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
CL100 expression is down-regul ...... eases its malignant potential.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P4510
P478
P50
P577
P5875
P6179
P698
P921